Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.
Hiroaki IkesueKaori KusudaYukari SatsumaFuki NishiwakiRieko MiuraYoshio MasudaMasaki HirabatakeNobuyuki MuroiDaichi FujimotoTakeshi MorimotoKeisuke TomiiTohru HashidaPublished in: Journal of clinical pharmacy and therapeutics (2020)
PBPM-based pharmacist-facilitated laboratory monitoring systems provided higher executing rate of laboratory order to monitor irAEs during immunotherapy.
Keyphrases